RGNX
Biotechnology · Healthcare
CEO
Equibles does not estimate personal net worth.
Get an email with a short summary when REGENXBIO Inc. publishes a filing, an earnings call transcript or a press release.
Get RGNX alertsKen Mills is recorded as CEO at REGENXBIO Inc. (RGNX). Ken Mills has spoken on 15 earnings calls and 1 other investor event across 1 company, most recently for REGENXBIO Inc. on September 15, 2026. REGENXBIO Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at REGENXBIO Inc. includes Curran M. Simpson (CEO, COO and Board Member), Allan M. Fox (Chairman and Board Member), George Migausky (Chairman and Board Member) and 7 others.
“We've been in business for roughly 15 years. working on AAV, primarily AAV8 and AAV9 as the base capsids that we've been innovating on. The company is really divided into two different areas.”
“I’m pleased to begin today’s call with a recap of our recent business highlights as well as an update on our corporate goals.”
“I'm pleased to begin today's call with an explanation of our updated strategic plan. Dr. Steve Pakola, our Chief Medical Officer, will then provide an update on our clinical programs.”
“I'm pleased to begin today's call with a recap of some recent business highlights, as well as an update on our corporate goals.”
“I'm pleased to begin today's call by recapping our recent business highlights as well as providing an update on our corporate goals.”
RGNX
Biotechnology · Healthcare
CEO